Best U.S. Cannabis Stocks for April 2026: Growth, Scale, and Opportunity

Impact · against what's priced in

Trulieve's strong scale and profitability make it the clear quality leader in the sector, while Cresco's shift toward profitability is tempered by industry-wide pricing pressure. Glass House Brands faces significant execution risks in California, evidenced by negative EBITDA and margin decay.

TCNNF+0.60: No priced-in read yet
In context: Trulieve demonstrates significant scale and efficiency with $1.2 billion in annual revenue, nearly 60% gross margins, and adjusted EBITDA exceeding $400 million.
Read from the article alone

Best U.S. Cannabis Stocks for April 2026: Growth, Scale, and Opportunity

cannabis▲500%
retail
cash flow
CRLBF
GLASF
TCNNF
federal reform
margins
marijuana
multi state operators

Best U.S. Cannabis Stocks for April 2026: Growth, Scale, and Opportunity

What matters in this story

Cannabix Technologies to Present Multi-Drug Breath Technology at BC Centre for Excellence on Substance Use Disorders

Best U.S. Cannabis Stocks for April 2026: Growth, Scale, and Opportunity

What matters in this story

Cannabix Technologies to Present Multi-Drug Breath Technology at BC Centre for Excellence on Substance Use Disorders

How each ticker is affected

Connected tickers

Track these names every morning.

Curaleaf Unlikely To Acquire Aurora Cannabis, But Long-Term Potential Remains

Kaplan Fox Alerts Investors of lululemon athletica inc. (LULU) with Significant Losses to a Securities Class Action Deadline on January 4, 2027

CVS Breakup Won't Satisfy Washington. It Could Still Work for Wall Street.

Leidos Q3: Mission Intact

Best U.S. Cannabis Stocks for April 2026: Growth, Scale, and Opportunity

What matters in this story

Next reads from the same story arc

Cannabix Technologies to Present Multi-Drug Breath Technology at BC Centre for Excellence on Substance Use Disorders

Best U.S. Cannabis Stocks for April 2026: Growth, Scale, and Opportunity

What matters in this story

Next reads from the same story arc

Cannabix Technologies to Present Multi-Drug Breath Technology at BC Centre for Excellence on Substance Use Disorders

How each ticker is affected

Connected tickers

Track these names every morning.

Curaleaf Unlikely To Acquire Aurora Cannabis, But Long-Term Potential Remains

Kaplan Fox Alerts Investors of lululemon athletica inc. (LULU) with Significant Losses to a Securities Class Action Deadline on January 4, 2027

CVS Breakup Won't Satisfy Washington. It Could Still Work for Wall Street.

Leidos Q3: Mission Intact